Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Comenzo

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Hospital Practice (1995)|August 15, 1996
Advances in the treatment of plasma cell diseasesR L Comenzo
Leukemia & Lymphoma|April 7, 2000
Hematopoietic cell transplantation for primary systemic amyloidosis: what have we learnedR L Comenzo
Current Treatment Options in Oncology|June 12, 2002
Primary systemic amyloidosisR L Comenzo
QJM : Monthly Journal of the Association of Physicians|January 7, 2012
Amyloid diseases of the heart: current and future therapiesS W Dubrey, R L Comenzo
Transfusion|April 1, 1995
Hematopoietic stem and progenitor cells from blood: emerging uses for new components for transfusionR L Comenzo, E M Berkman
The New England Journal of Medicine|September 26, 1997
The systemic amyloidosesR H Falk, R L Comenzo, M Skinner
Bone Marrow Transplantation|June 17, 2014
Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosisE Kaul, G Shah, C Chaulagain, et al.
Blood|July 27, 2001
The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burdenR L Comenzo, Y Zhang, C Martinez, et al.
Gene Therapy|July 8, 2016
siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseasesX Ma, P Zhou, S W Wong, et al.
British Journal of Haematology|September 1, 1999
Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantationR L Comenzo, J Wally, G Kica, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Hospital Practice (1995)|August 15, 1996
Advances in the treatment of plasma cell diseasesR L Comenzo
Leukemia & Lymphoma|April 7, 2000
Hematopoietic cell transplantation for primary systemic amyloidosis: what have we learnedR L Comenzo
Current Treatment Options in Oncology|June 12, 2002
Primary systemic amyloidosisR L Comenzo
QJM : Monthly Journal of the Association of Physicians|January 7, 2012
Amyloid diseases of the heart: current and future therapiesS W Dubrey, R L Comenzo
Transfusion|April 1, 1995
Hematopoietic stem and progenitor cells from blood: emerging uses for new components for transfusionR L Comenzo, E M Berkman
The New England Journal of Medicine|September 26, 1997
The systemic amyloidosesR H Falk, R L Comenzo, M Skinner
Bone Marrow Transplantation|June 17, 2014
Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosisE Kaul, G Shah, C Chaulagain, et al.
Blood|July 27, 2001
The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burdenR L Comenzo, Y Zhang, C Martinez, et al.
Gene Therapy|July 8, 2016
siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseasesX Ma, P Zhou, S W Wong, et al.
British Journal of Haematology|September 1, 1999
Clonal immunoglobulin light chain variable region germline gene use in AL amyloidosis: association with dominant amyloid-related organ involvement and survival after stem cell transplantationR L Comenzo, J Wally, G Kica, et al.
Pageof 5